| 000 | 00951 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517021850.0 | ||
| 264 | 0 | _c20160509 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/1381612821666150310141827 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, Philip M | |
| 245 | 0 | 0 |
_aRheumatoid arthritis: an evolutionary force in biologics. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2015 |
||
| 300 |
_a2170-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 700 | 1 | _aIsaacs, John D | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 21 _gno. 17 _gp. 2170-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612821666150310141827 _zAvailable from publisher's website |
| 999 |
_c24697493 _d24697493 |
||